Related content

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

By Jiang Jingwei   Huang Lizhen   Liang Xiaohua   Zhou Xinli   Huang Ruofan   Chu Zhaohui   Zhan Qiong  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 633-638

Science Publishers

Access to resources Recommend Favorite

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis

By Liu Yu   Yin Tie-Jun   Zhou Rong   Zhou Si   Fan Liang   Zhang Rong-Ge  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1125-1132

Springer Publishing Company

Access to resources Recommend Favorite

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

By Long Anne   Ferraro Danielle   Stockler Martin   Blinman Prunella  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer

By Wang Linrun   Wu Xiuhua   Huang Mingzhu   Cai Jie   Xu Nong   Liu Jian  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite